STI571

This publication has 9 references indexed in Scilit:

• Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
  New England Journal of Medicine, 2001
• Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
  New England Journal of Medicine, 2001
• Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
  New England Journal of Medicine, 2001
• Gastrointestinal stromal tumors: their origin and cause.
  International Journal of Clinical Oncology, 2001
• Activating and dominant inactivating c-KITcatalytic domain mutations in distinct clinical forms of human mastocytosis
  Proceedings of the National Academy of Sciences, 1999
• Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or Leiomyosarcomas
  The American Journal of Pathology, 1999
• CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins
  Blood, 1997
• Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives
  Bioorganic & Medicinal Chemistry Letters, 1997
• Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
  Science, 1990